RecruitingObservational

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia (AML) Using Remote Symptom Monitoring

NCT ID: NCT05974150Sponsor: Carevive Systems, Inc.Last updated: 2026-02-23

Summary

The goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic care planning system (CPS) with remote symptom monitoring that is used in routine care for cancer patients on active treatment. Patients will complete a baseline survey in person using a secured device or remotely using their own electronic device in a location of their choice. Weekly electronic patient reported outcome (PRO) surveys are collected from the patients using the Carevive platform for a minimum of 12 weeks. Patients may continue weekly surveys as long as they are receiving treatment.

Arms & interventions

OtherWeb based survey
online weekly survey

Outcome measures

Primary

Create Data Set
The goal of this registry is to create a data set from real world clinical and patient reported data collected using an electronic care planning system (CPS) that is used in routine care for cancer patients on active treatment
Time frame: 1 year

Eligibility criteria

Sex: AllAge: 18 Years and olderHealthy volunteers: No

Inclusion Criteria: * All participants must be 18 years of age or older. * Subjects may be any stage and anywhere in the treatment continuum. * Subject participants must have a diagnosis of a breast, lung, AML, ovarian cancer or multiple myeloma. * Subjects must be able to complete on-line surveys using a cell phone, tablet, or computer. * All participants must be able to understand English. Exclusion Criteria: * Any patient who cannot understand written or spoken English. * Any patient without the ability to complete on-line surveys using a cell phone, tablet, or computer. * Any patient on a treatment clinical trial. * Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C and D).

Study locations (7)

Yale Cancer Center

New Haven, Connecticut, 06511

Completed

Northshore University Health System

Evanston, Illinois, 31024

Recruiting

Michele Britto · Contact

MBritto@northshore.org

Nicklas Pfanzelter · Principal Investigator

Univeristy of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27599

Completed

Duke

Durham, North Carolina, 27707

Completed

Cleveland Clinic Mercy Hospital

Canton, Ohio, 44708

Recruiting

Janet Muckley · Contact

MUCKLEJ@ccf.org

Mitchell Haut, MD · Principal Investigator

University Hospitals Seidman Cancer Center

Cleveland, Ohio, 44106

Recruiting

Jill Severino-Powell, MSN · Contact

Jill.Severino-Powell@UHhospitals.org

Alberto Montero, MD · Principal Investigator

Tri-County Hematology & Oncology Associates, Inc.

Massillon, Ohio, 44646

Recruiting

Janet Muckley · Contact

MUCKLEJ@ccf.org

Nagaprasad Nagajothi, MD · Principal Investigator